What is Chemify?
Headquartered in Glasgow, Scotland, and founded by Lee Cronin, Chemify is fundamentally altering the landscape of molecular research. The company utilizes its unique Chemputation platform to automate the discovery and synthesis of novel medicines and advanced materials. By treating chemical reactions as programmable digital processes, Chemify enables researchers to execute complex synthesis workflows with unprecedented reliability and speed. This fusion of robotics and AI-driven software allows for the rapid iteration of chemical structures, effectively removing the traditional bottlenecks associated with manual laboratory experimentation and accelerating the time-to-market for critical innovations.
How much funding has Chemify raised?
Chemify has raised a total of $93M across 2 funding rounds:
Series A
$43M
Series B
$50M
Series A (2023): $43M with participation from Possible Ventures and Horizon Ventures
Series B (2025): $50M led by 8VC, Triatomic Capital, Wing Venture Capital, Insight Partners, and BlueYard Capital
Key Investors in Chemify
8VC
A leading technology investment firm that backs visionary teams and industry-transforming companies, with a strong focus on smart enterprise platforms and Bio-IT.
Triatomic Capital
An investment firm specializing in deep tech and health tech, targeting century-defining technologies in engineered biology and next-generation computing.
Wing Venture Capital
An early-stage investor and company builder that provides resources and strategic partnerships to founders developing innovative AI and autonomous applications.
What's next for Chemify?
With the successful closure of this major strategic investment, Chemify is poised to transition into a period of aggressive operational expansion. The company's roadmap focuses on scaling its Chemputation infrastructure to support broader industrial applications, ranging from pharmaceutical development to the creation of next-generation materials. As the firm continues to refine its AI models and robotic hardware, it is expected to forge deeper partnerships with global enterprise entities seeking to digitize their R&D pipelines. The focus remains on establishing a standardized, scalable framework for chemical production that can be deployed across diverse sectors, ultimately cementing Chemify's role as the foundational layer for the future of automated molecular manufacturing.
See full Chemify company page
